Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2008

View Archived Issues

New role for endogenous microRNAs in cancer metastasis discovered

Readthrough AChE splice variant may be linked to Abeta pathology in AD

Avalon initiates characterization of identified compounds from collaboration with Novartis

Nventa reports positive data from second cohort of patients in phase I clinical trial of HspE7

Interim analysis recommends continuation of VITAL-1 trial of GVAX immunotherapy

Schering-Plough reports results from IDEAL study comparing leading hepatitis C therapies

Ankrd26 gene disruption gives rise to obesity and gigantism in mice

FDA sends warning letters over compounded menopause hormone therapy drugs

Novel antidiabetic agents disclosed in recent Merck Frosst patent

Recent AstraZeneca and Icos patents describe new agents for respiratory and allergic disorders

Recent patents disclose new therapeutic agents for obesity and lipoprotein disorders

Amkor's stroke drug nears end of phase I and prepares for phase II in 2008

BioCancell receives FDA approval for phase IIb bladder cancer study

Biofrontera initiates phase III BF-200 ALA trial in actinic keratosis

Pfizer submits NDA for Fablyn in osteoporosis

NDA filed for Keppra XR extended-release tablets

Alvesco gains FDA approval for asthma therapy

Glenmark's lead diabetes candidate named melogliptin

Head to head study comparing rosuvastatin and atorvastatin commences

Pozen submits human lymphocyte study for Treximet to the FDA

VGX receives FDA clearance to commence clinical trials of VGX-1027

ZymoGenetics and Merck receive FDA agreement for atacicept SPA in general SLE

Preliminary results for RVX-208 phase I study show good safety and tolerability

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...